Literature DB >> 26329380

Withdrawal syndrome after co-medication of opioid maintenance therapy with nalmefene: unrecognized interaction.

Caroline Diot1, Céline Eiden1, Anne Roussin2, Anne Batisse3, Alexandra Boucher4, François Chavant5, Amélie Daveluy6, Hélène Donadieu-Rigole7, Hélène Peyrière8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26329380     DOI： 10.1007/s00228-015-1931-y

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

1.  [Naltrexone and opiate substitutive treatment].

Authors:  Julie Dupouy; Jean-Christophe Poutrain; Maryse Lapeyre-Mestre
Journal:  Therapie       Date:  2011-12-21       Impact factor: 2.070

2.  Signal identification in addictovigilance: the functioning of the French system.

Authors:  Emilie Jouanjus; Valérie Gibaja; Jean-Pierre Kahn; Françoise Haramburu; Amélie Daveluy
Journal:  Therapie       Date:  2015-04-09       Impact factor: 2.070

3.  Severe opioid withdrawal syndrome after a single dose of nalmefene.

Authors:  Nadine Donnerstag; Tobias Schneider; Adrian Lüthi; Anne Taegtmeyer; Alexandra Raetz Bravo; Annekathrin Mehlig
Journal:  Eur J Clin Pharmacol       Date:  2015-06-07       Impact factor: 2.953

4.  First case of stress cardiomyopathy as a result of methadone withdrawal secondary to drug-drug interaction.

Authors:  Frédéric Lemesle; Florence Lemesle; Walid Nicola; Annie Pierre Jonville-Béra
Journal:  Am J Emerg Med       Date:  2010-03       Impact factor: 2.469

5.  Opiate withdrawal complicated by tetany and cardiac arrest.

Authors:  Irfanali R Kugasia; Nehad Shabarek
Journal:  Case Rep Crit Care       Date:  2014-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.